YSB：Digitalizing outside-of-hospital pharmaceutical circulation market in China

 YSB specializes in providing digital solutions in China’s outside-of-hospital  pharmaceutical circulation market. According to Frost & Sullivan (F&S), the  Company is the largest digital pharmaceutical platform serving businesses outside  of hospitals in China, taking a market share of 21.0% in 2022 in terms of GMV  (gross merchandise volume). YSB’s business model mainly includes Online  Marketplace and Self-operation Business (including Targeted Product Launch  Business).









Comments

Post a Comment

Popular posts from this blog

Sizing the “New Three” in the Chinese Economy

Image
  Policymakers and investors often refer to battery, new energy vehicle (NEV) and renewable energy as the “New Three” of the Chinese economy, in comparison to the “Old Three” such as furniture, home appliance and clothing in Chinese exports; or property, infrastructure and processing trade in the overall economy. NEV and battery production, as well as renewable energy capex, have seen significant increases in recent years and are expected to continue growing rapidly in coming years, adding to headline GDP growth in China. 
Read more

A brand's quide to Chinese gifting habits 2023

Image
  Gift giving is becoming a daily habit, with Chinese people gifting more often and casually.  Gifting is vital in strengthening roles within harmonious relationships.  Health/wellness are rising in popularity as gift givers seek ways to support the wellbeing of  others.  Personalization/customization, interactive experiences, and an “expensive yet sophisticated”  look can make products more appealing.  Festive occasions, notably the Chinese New Year, let brands showcase their cultural  understanding through gifts.  Gift givers rely on social media as a source of gifting inspiration
Read more